Racial Disparities in Breast Cancer Mortality are Not Driven by Estrogen Receptor Status Alone – 2
Narrator: This is NIH Health Matters. A new study identifies factors for differences in rates of breast cancer in black vs. white women. Dr. Idan Menashe is the lead author of the study and research fellow at in the National Cancer Institute's Division of Cancer and Epidemiology and Genetics. He says one factor is the biological differences between these two populations.
Menashe: We know that black women tend to have higher prevalence of the estrogen receptor negative, or we call it ER negative, tumors which are the more aggressive and more difficult to treat tumors. And therefore people suggest that these differences could account for this racial gap.
Narrator: Another factor is access to care. For details on the study, visit www.cancer.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.